In a two-year follow-up for a subgroup of patients, FDDNP-PET showed that nine clinically stable patients (seven controls and two with mild cognitive impairment) had only minimal increases in global FDDNP binding (≤ 3%).
In a two-year follow-up for a subgroup of patients, FDDNP-PET showed that nine clinically stable patients (seven controls and two with mild cognitive impairment) had only minimal increases in global FDDNP binding (≤ 3%).
在对各组志愿者两年的跟踪观察中，FDDNP-PET结合检测表明，临床稳定的9人（7人对照，2人轻微减退）的总体结合值仅有微量增加（≤3%）。